An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (101)
  • Training (0)
  • User case (3)
  • User meeting (0)
  • Webinar (1)
  • White paper (3)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • (-) Sarcomas (18)
  • (-) Thoracic (91)
  • Reset filters
  • (-) Sarcomas
  • (-) Thoracic

Proton Beam Therapy for Esophageal Cancer.

15/11/2022
/ Publications
/
Clinical Trial

A latest review examined the existing of PBT for locally advanced esophageal cancer, including dosimetric comparative studies, early clinical outcome...

Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.

15/11/2022
/ Publications
/
Hypofractionation

This systematic review evaluated eight studies and 401 patients with early stage NSCLC treated with hypofractionated PBT to a median total dose of 63 Gy(RBE)...

Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.

15/11/2022
/ Publications
/
IMPT
IMRT

163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...

Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.

15/11/2022
/ Publications

A study by the Samsung group Korea reported the clinical outcomes of 168 patients with early stage of NSCLC treated by photon SBRT and 34 with proton SBRT...

Lung treatment with pencil beam scanner at the Texas Center of Proton Therapy

01/01/2017
/ Event
/
Pencil Beam Scanning - PBS
Proton therapy center

The Texas Center for Proton Therapy brings an advanced cancer treatment to North Texas that offers more hope to cancer patients. The 63,000-square-foot center...

Clinical experience from the first compact IMPT Proton Therapy Center: the advantages of treating in an open gantry environment

26/01/2018
/ Event
/
IMPT

The Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care...

Emerging Proton Therapy Indication: Lung Cancer

24/02/2023
/ Webinar
/
PT101

Joe Chang gives a presentation on using proton therapy for lung cancer. He talks about the advantages over photons, the improvements of IMPT compared to PSPT...

High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.

01/03/2024
/ Publications

This study reported results of PBS-PT (60 GyRBE in 30 fractions) and immunotherapy for 29 patients with locally advanced (stage IIB to IIIC, 90%) high-risk...

Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era.

01/03/2024
/ Publications

This study reported results in 22 patients with recurrent NSCLC received IMPT reirradiation to a total mean dose of 60GyE. The first course of radiation was 60...

Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.

01/03/2024
/ Publications

This report presented the results of patients with non-CNS malignancies treated in the UK proton overseas program. Four hundred and ninety-five patients were...

Pagination

  • Previous page ‹
    • Page 6
    • Current page 7
    • Page 8
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies